Maimon Yossi - Net Worth and Insider Trading
Maimon Yossi Net Worth
The estimated net worth of Maimon Yossi is at least $22,620 dollars as of 2024-11-10. Maimon Yossi is the Vice President & CFO of Protalix BioTherapeutics Inc and owns about 19,500 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $22,620. Details can be seen in Maimon Yossi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Maimon Yossi has not made any transactions after 2015-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Maimon Yossi
Maimon Yossi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Maimon Yossi owns 2 companies in total, including Ayala Pharmaceuticals Inc (ADXS) , and Protalix BioTherapeutics Inc (PLX) .
Click here to see the complete history of Maimon Yossi’s form 4 insider trades.
Insider Ownership Summary of Maimon Yossi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADXS | Ayala Pharmaceuticals Inc | 2020-05-07 | CFO |
| PLX | Protalix BioTherapeutics Inc | 2015-12-14 | VP & Chief Financial Officer |
Maimon Yossi Latest Holdings Summary
Maimon Yossi currently owns a total of 1 stock. Maimon Yossi owns 19,500 shares of Protalix BioTherapeutics Inc (PLX) as of December 14, 2015, with a value of $22,620.
Latest Holdings of Maimon Yossi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2015-12-14 | 19,500 | 1.16 | 22,620 |
Holding Weightings of Maimon Yossi
Maimon Yossi Form 4 Trading Tracker
According to the SEC Form 4 filings, Maimon Yossi has made a total of 0 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years. The most-recent trade in Protalix BioTherapeutics Inc is the acquisition of 1,000 shares on December 14, 2015, which cost Maimon Yossi around $7,800.
Insider Trading History of Maimon Yossi
- 1
Maimon Yossi Trading Performance
GuruFocus tracks the stock performance after each of Maimon Yossi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Maimon Yossi is 19.23%. GuruFocus also compares Maimon Yossi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Maimon Yossi within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Maimon Yossi's insider trading performs compared to the benchmark.
Performance of Maimon Yossi
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.97 | | | | | |
| Relative Return to S&P 500(%) | 13.92 | | | | | |
Maimon Yossi Ownership Network
Ownership Network List of Maimon Yossi
Ownership Network Relation of Maimon Yossi
Maimon Yossi Owned Company Details
What does Ayala Pharmaceuticals Inc do?
Who are the key executives at Ayala Pharmaceuticals Inc?
Maimon Yossi is the CFO of Ayala Pharmaceuticals Inc. Other key executives at Ayala Pharmaceuticals Inc include other: shareholder of 10% holder Yair Chaim Schindel , director & CEO Roni Mamluk , and Chief Medical Officer Gary B. Gordon .
Ayala Pharmaceuticals Inc (ADXS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ayala Pharmaceuticals Inc (ADXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ayala Pharmaceuticals Inc (ADXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ayala Pharmaceuticals Inc (ADXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ayala Pharmaceuticals Inc Insider Transactions
Maimon Yossi Mailing Address
Above is the net worth, insider trading, and ownership report for Maimon Yossi. You might contact Maimon Yossi via mailing address: C/o Protalix Biotherapeutics, Inc., 2 Snunit St, Science Park, Pob 455, Carmiel L3 20100.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
